Literature DB >> 19192392

Flavonoids inhibit the AU-rich element binding of HuC.

Hojoong Kwak1, Kyung-Chae Jeong, Min-Ju Chae, Soo-Youl Kim, Woong-Yang Park.   

Abstract

Post-transcriptional regulation of mRNA stability by Hu proteins is an important mechanism for tumorigenesis. We focused on the molecular interactions between the HuC protein and AU-rich elements (AREs) to find chemical inhibitors of RNA-protein interactions using RNA electrophoretic mobility shift assay with non-radioactive probes. Screening of 52 natural compounds identified 14 candidate compounds that displayed potent inhibitory activity. Six (quercetin, myricetin, (-)-epigallocatechin gallate, ellagic acid, (-)-epicatechin gallate, and rhamnetin) were categorized as phytochemicals, and their IC(50) values were low (0.2-1.8 microM). [BMB reports 2009; 42(1): 41-46].

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192392     DOI: 10.5483/bmbrep.2009.42.1.041

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  4 in total

1.  miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1.

Authors:  Himanshu Arora; Rehana Qureshi; Shunzi Jin; Ae Kyoung Park; Woong Yang Park
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

2.  Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA.

Authors:  Min-Ju Chae; Hye Youn Sung; Eun-Hye Kim; Mira Lee; Hojoong Kwak; Chong Hak Chae; Sunwoo Kim; Woong-Yang Park
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

3.  Investigation of the interaction between the MIR-503 and CD40 genes in irradiated U937 cells.

Authors:  Guanghui Cheng; Shilong Sun; Zhanfeng Wang; Shunzi Jin
Journal:  Radiat Oncol       Date:  2012-03-20       Impact factor: 3.481

4.  Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.

Authors:  Jana Koo; Stephanie Cabarcas-Petroski; John L Petrie; Nicole Diette; Robert J White; Laura Schramm
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.